• Maher Abouzeid joins healthcare private equity firm TVM Capital Healthcare as an Operating Partner.
  • He has 25 years of international healthcare management experience, including his tenure with GE Healthcare where he was President & CEO covering Eastern Growth Markets across Diagnostic Imaging, Life Care Solution & Life Science

 

[Dubai], 24. April 2019: Healthcare private equity firm TVM Capital Healthcare has appointed Maher Abouzeid as an Operating Partner. Maher Abouzeid is a highly experienced healthcare executive with 25 years of international commercial management experience in the medical device and equipment sectors.

 

He will engage with the firm’s portfolio and new projects. His first assignment is to support the international expansion of portfolio company, Amecath Medical Technologies, an Egypt-based medical device manufacturer. Mr. Abouzeid will focus specifically on market entry and growth in the largest medical device markets in the world, the USA and several of the large European countries.

 

By supplying leadership and mangement functions, TVM Capital Healthcare supports its portfolio with its growth strategies and allows its companies to benefit from a pool of industry experts who have worked in the field of healthcare with more than 200 years of combined experience in healthcare markets, holding leading management positions in the USA, Europe, the MENAT region and across Asia.

 

Commenting on his appointment, Mr. Abouzeid said: “I am delighted to join TVM Capital Healthcare’s team of Operating Partners and grow Amecath’s growing international footprint. Amecath is a successful home-grown Egyptian business with globally competitive intellectual property and an ISO-certified manufacturing process. The opportunity is exciting, and I look forward to helping lead Amecath into international expansion and success.”

 

Mr. Abouzeid joins TVM Capital Healthcare from GE Healthcare where he was President & CEO covering Eastern Growth Markets across Diagnostic Imaging, Life Care Solutions & Life Science. He previously served as DePuy Franchise Director at Johnson & Johnson Medical, and started his career at 3M Healthcare, leading the business in the Middle East.

 

Dr. Helmut M. Schuehsler, CEO and Chairman at TVM Capital Healthcarecommented: “We are thrilled that Maher joined us to strengthen  our global investment strategy in the medical device and equipment manufacturing field.  We undertake extensive research to identify unmet healthcare needs and invest in companies that are best positioned and equipped to fill the gaps.

 

Amecath is a prime example of the success of this model, as a manufacturer of high-quality medical products for international markets, at a highly competitive price point. We firmly believe that Maher’s international experience with three major healthcare multinationals in this product space will enable us to elevate the business to its next stage of growth and find and invest in other businesses just like it.”